Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7498200 | 0.85 | L3MBTL1 (0.59) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL6441147 | 0.84 | HTT (0.73) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL19940614 | 0.84 | ALDH1A1 (0.51) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL21594659 | 0.84 | SMN1; SMN2 (0.63) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL18997822 | 0.84 | SMN1; SMN2 (0.63) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL23270942 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| Acetyl Sumiki'S Acid SCHEMBL168107 | 0.83 | NPC1 (0.58) | SMN1; SMN2NPC1RAB9AHSP90AA1KMT2A | |
| SCHEMBL21594673 | 0.83 | SMN1; SMN2 (0.48) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL21594674 | 0.83 | SMN1; SMN2 (0.48) | SMN1; SMN2HPGDHTTNPC1RAB9A | |
| SCHEMBL22856757 | 0.82 | HTT (0.47) | SMN1; SMN2HPGDHTTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638888-B | Oxidation process for the production of 5- (alkoxycarbonyl) furan-2-carboxylic Acid (ACFC) | 伊士曼化工公司 | 2024-04-02 | — | — | CN | claimed |
| EP-3810584-A1 | AN OXIDATION PROCESS TO PRODUCE 5-(ALKOXYCARBONYL)FURAN-2-CARBOXYLIC ACIDS(ACFC) | Eastman Chemical Company (US) | 2021-04-28 | — | — | EP | claimed |
| CN-112638888-A | Oxidation process for the production of 5- (alkoxycarbonyl) furan-2-carboxylic Acid (ACFC) | 伊士曼化工公司 | 2021-04-09 | — | — | CN | claimed |
| US-10941245-B2 | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) | EASTMAN CHEMICAL COMPANY (US) | 2021-03-09 | — | — | US | claimed |
| US-10544118-B2 | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) | EASTMAN CHEMICAL COMPANY (US) | 2020-01-28 | — | — | US | claimed |
| US-20250223272-A1 | COOLING PROCESSES TO PRODUCE ACFC WITH INCREASED CRYSTAL SIZE WITH PURGE | EASTMAN CHEMICAL COMPANY (US) | 2025-07-10 | — | — | US | disclosed |
| EP-4025567-B1 | EFFICIENT PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)-FURAN-2-CARBOXYLIC ACIDS | EASTMAN CHEM CO (US) | 2025-04-23 | — | — | EP | disclosed |
| EP-4508041-A1 | COOLING PROCESSES TO PRODUCE ACFC WITH INCREASED CRYSTAL SIZE WITH PURGE | Eastman Chemical Company (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20250026729-A1 | INTEGRATED PROCESS FOR 5-(METHOXYCARBONYL)FURAN-2-CARBOXYLIC ACID (MCFC) | EASTMAN CHEMICAL COMPANY (US) | 2025-01-23 | — | — | US | disclosed |
| US-20240317698-A1 | MOTHER LIQUOR COMPOSITION GENERATED IN MCFC PROCESS | EASTMAN CHEMICAL COMPANY (US) | 2024-09-26 | — | — | US | disclosed |
| US-20240270708-A1 | PURGE PROCESS FOR 5-(ALKOXYCARBONYL)FURAN-2-CARBOYLIC ACID (ACFC) | EASTMAN CHEMICAL COMPANY (US) | 2024-08-15 | — | — | US | disclosed |
| CN-114364662-B | Efficient process for producing 5- (alkoxycarbonyl) -furan-2-carboxylic acid | 伊士曼化工公司 | 2024-07-12 | — | — | CN | disclosed |
| US-10941245-B2 | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) | EASTMAN CHEMICAL COMPANY (US) | 2021-03-09 | — | — | US | disclosed |
| US-10941245-B2 | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) | EASTMAN CHEMICAL COMPANY (US) | 2021-03-09 | — | — | US | disclosed |
| US-10544118-B2 | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) | EASTMAN CHEMICAL COMPANY (US) | 2020-01-28 | — | — | US | disclosed |
| US-10544118-B2 | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) | EASTMAN CHEMICAL COMPANY (US) | 2020-01-28 | — | — | US | disclosed |
| US-20190389846-A1 | PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)FURAN-2-CARBOXYLIC ACIDS AND COMPOSITIONS CONTAINING SAME | EASTMAN CHEMICAL COMPANY (US) | 2019-12-26 | — | — | US | disclosed |
| US-20190389846-A1 | PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)FURAN-2-CARBOXYLIC ACIDS AND COMPOSITIONS CONTAINING SAME | EASTMAN CHEMICAL COMPANY (US) | 2019-12-26 | — | — | US | disclosed |
| WO-2017112777-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC (US) | 2017-06-29 | — | — | WO | disclosed |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10941245-B2 | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) | MCCC2, ACSL5, ACACB | SMN1; SMN2 3106/4885HPGD 872/4885HTT 4744/4885 |
| US-20250223272-A1 | COOLING PROCESSES TO PRODUCE ACFC WITH INCREASED CRYSTAL SIZE WITH PURGE | ACACA, ADCY10, MCCC2 | SMN1; SMN2 2528/4885HPGD 2475/4885HTT 4250/4885 |
| US-20240317698-A1 | MOTHER LIQUOR COMPOSITION GENERATED IN MCFC PROCESS | MCCC2, MLEC, ACSL5 | SMN1; SMN2 2033/4885HPGD 1446/4885HTT 4779/4885 |
| US-20190389846-A1 | PROCESS FOR PRODUCING 5-(ALKOXYCARBONYL)FURAN-2-CARBOXYLIC ACIDS AND COMPOSITIONS CONTAINING SAME | CA5B, ACSL5, CA5A | SMN1; SMN2 1099/4885HPGD 1360/4885HTT 4198/4885 |
| US-10544118-B2 | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) | MCCC2, ACSL5, ACACB | SMN1; SMN2 3053/4885HPGD 766/4885HTT 4790/4885 |
| US-20240270708-A1 | PURGE PROCESS FOR 5-(ALKOXYCARBONYL)FURAN-2-CARBOYLIC ACID (ACFC) | MCCC2, ACACB, ACACA | SMN1; SMN2 3140/4885HPGD 967/4885HTT 4612/4885 |
| US-20250026729-A1 | INTEGRATED PROCESS FOR 5-(METHOXYCARBONYL)FURAN-2-CARBOXYLIC ACID (MCFC) | MCCC2, RFC5, ACSL5 | SMN1; SMN2 2055/4885HPGD 2973/4885HTT 3549/4885 |
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | MAPK6, MAP3K6, MAPK4 | SMN1; SMN2 4331/4885HPGD 365/4885HTT 4394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.